Patents by Inventor Daniel D Sohn

Daniel D Sohn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tartrate salts of (R) -3-N,N- dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1- benzopyran-5-carboxamide
    Patent number: 6858645
    Abstract: A new salt (R)-3-N,N-dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide hydrogen tartrate, particularly the (2R,3R)-tartrate thereof, most particularly the (R)-3-N,N-dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide hydrogen (2R,3R)-tartrate monohydrate, processes for the manufacture of said tartrate salt, the use of the salt in medicine, the use of the tartrate salt in the manufacture of pharmaceutical formulations, and a method for the treatment of CNS disorders by administration of the tartrate salt to a host in need of such treatment.
    Type: Grant
    Filed: May 15, 1998
    Date of Patent: February 22, 2005
    Assignee: AstraZeneca AB
    Inventors: Hakan Nyqvist, Daniel D Sohn
  • TARTRATE SALTS OF (R) -3-N,N- DICYCLOBUTYLAMINO-8-FLUORO-3,4-DIHYDRO-2H-1- BENZOPYRAN-5-CARBOXAMIDE
    Publication number: 20030109576
    Abstract: A new salt (R)-3-N,N-dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide hydrogen tartrate, particularly the (2R,3R)-tartrate thereof, most particularly the (R)-3-N,N-dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide hydrogen (2R,3R)-tartrate monohydrate, processes for the manufacture of said tartrate salt, the use of the salt in medicine, the use of the tartrate salt in the manufacture of pharmaceutical formulations, and a method for the treatment of CNS disorders by administration of the tartrate salt to a host in need of such treatment.
    Type: Application
    Filed: June 8, 1998
    Publication date: June 12, 2003
    Inventors: HAKAN NYQVIST, DANIEL D SOHN